Loading...
If your product does not perform as described on this datasheet, we will refund or replace your product...
Read our guarantee »Products:Signal Transduction >> Cytoskeleton / ECM >> Cytoskeleton >> Intermediate Filaments >> Class I >> Cytokeratins
Anti-Cytokeratin 5 antibody [EP1601Y]
See all Cytokeratin 5 products (13) ...
Rabbit monoclonal [EP1601Y] to Cytokeratin 5
Mouse reactivity is based on IHC ( positive tissues: liver,lung,brain,skin). However, WB was negative for Mouse brain, heart, kidney and spleen.
IHC-Fr, ICC/IF, IHC-P, WB, IHC-Pmore details
Reacts with
Mouse, Human
Does not react with
Rat
Synthetic peptide (Human)
A431 cells. Human transitional urinary bladder carcinoma.
Liquid
Store at -20°C. Stable for 12 months at -20°C
Preservative: 0.01% Sodium Azide
Constituents: 40% Glycerol, 0.05% BSA, 0.15M Sodium chloride, 50mM Tris glycine, pH 7.4
Tissue culture supernatant
Monoclonal
EP1601Y
IgG
Signal Transduction >> Cytoskeleton / ECM >> Cytoskeleton >> Intermediate Filaments >> Class I >> Cytokeratins
Our Abpromise guarantee covers the use of ab52635 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
IHC-Fr: Use at an assay dependent concentration.
ICC/IF: Use at an assay dependent dilution. (PubMed: 20339138)
IHC-P: Use at an assay dependent concentration.
WB: 1/10000Detects a band of approximately 62 kDa (predicted molecular weight: 62 kDa).
IHC-P: 1/100 - 1/250.(An antigen retrieval step is recommended.)
Is unsuitable for or Flow Cyt.
Defects in KRT5 are a cause of epidermolysis bullosa simplex Dowling-Meara type (DM-EBS) [MIM:131760]. DM-EBS is a severe form of intraepidermal epidermolysis bullosa characterized by generalized herpetiform blistering, milia formation, dystrophic nails, and mucous membrane involvement.
Defects in KRT5 are the cause of epidermolysis bullosa simplex with migratory circinate erythema (EBSMCE) [MIM:609352]. EBSMCE is a form of intraepidermal epidermolysis bullosa characterized by unusual migratory circinate erythema. Skin lesions appear from birth primarily on the hands, feet, and legs but spare nails, ocular epithelia and mucosae. Lesions heal with brown pigmentation but no scarring. Electron microscopy findings are distinct from those seen in the DM-EBS, with no evidence of tonofilament clumping.
Defects in KRT5 are a cause of epidermolysis bullosa simplex Weber-Cockayne type (WC-EBS) [MIM:131800]. WC-EBS is a form of intraepidermal epidermolysis bullosa characterized by blistering limited to palmar and plantar areas of the skin.
Defects in KRT5 are a cause of epidermolysis bullosa simplex Koebner type (K-EBS) [MIM:131900]. K-EBS is a form of intraepidermal epidermolysis bullosa characterized by generalized skin blistering. The phenotype is not fundamentally distinct from the Dowling-Meara type, althought it is less severe.
Defects in KRT5 are the cause of epidermolysis bullosa simplex with mottled pigmentation (MP-EBS) [MIM:131960]. MP-EBS is a form of intraepidermal epidermolysis bullosa characterized by blistering at acral sites and 'mottled' pigmentation of the trunk and proximal extremities with hyper- and hypopigmentation macules.
Defects in KRT5 are the cause of Dowling-Degos disease (DDD) [MIM:179850]; also known as Dowling-Degos-Kitamura disease or reticulate acropigmentation of Kitamura. DDD is an autosomal dominant genodermatosis. Affected individuals develop a postpubertal reticulate hyperpigmentation that is progressive and disfiguring, and small hyperkeratotic dark brown papules that affect mainly the flexures and great skin folds. Patients usually show no abnormalities of the hair or nails.
Belongs to the intermediate filament family.
Target information above from: UniProt accessionP13647
The UniProt Consortium
The Universal Protein Resource (UniProt) in 2010
Nucleic Acids Res. 38:D142-D148 (2010).
Western blot - Cytokeratin 5 antibody [EP1601Y] (ab52635)
![Western blot - Cytokeratin 5 antibody [EP1601Y] (ab52635)](/ps/datasheet/Images/52/ab52635/ck51.jpg)
Anti-Cytokeratin 5 antibody [EP1601Y] (ab52635) at 1/10000 dilution + A431 cell lysate at 10 µg
Secondary
Goat anti-rabbit HRP at 1/2000 dilution
Predicted band size : 62 kDa
Observed band size : 62 kDa
Immunohistochemistry (Paraffin-embedded sections) - Cytokeratin 5 antibody [EP1601Y] (ab52635)
![Immunohistochemistry (Paraffin-embedded sections) - Cytokeratin 5 antibody [EP1601Y] (ab52635)](/ps/datasheet/Images/52/ab52635/ck52.jpg)
Human transitional urinary bladder carcinoma stained with ab52635 at 1/100 - 1/250 dilution.
Immunocytochemistry/ Immunofluorescence - Cytokeratin 5 antibody [EP1601Y] (ab52635)
![Immunocytochemistry/ Immunofluorescence - Cytokeratin 5 antibody [EP1601Y] (ab52635)](/ps/datasheet/Images/52/ab52635/ck53.jpg)
A431 cells stained with ab52635 at 1/100 - 1/250
This product has been referenced in:
See all 2 publications for this product
Publishing research using ab52635? Please let us know so that we can cite the reference in this datasheet
Concentration of lot no. is
Concentration not available for this lot.
Find concentration of your lot:
![Western blot - Cytokeratin 5 antibody [EP1601Y] (ab52635)](/ps/datasheet/Images/52/ab52635/ck51.jpg)
Anti-Cytokeratin 5 antibody [EP1601Y] (ab52635) at 1/10000 dilution + A431 cell lysate at 10 µg
Secondary
Goat anti-rabbit HRP at 1/2000 dilution
Predicted band size : 62 kDa
Observed band size : 62 kDa
![Immunohistochemistry (Paraffin-embedded sections) - Cytokeratin 5 antibody [EP1601Y] (ab52635)](/ps/datasheet/Images/52/ab52635/ck52.jpg)
Human transitional urinary bladder carcinoma stained with ab52635 at 1/100 - 1/250 dilution.
![Immunocytochemistry/ Immunofluorescence - Cytokeratin 5 antibody [EP1601Y] (ab52635)](/ps/datasheet/Images/52/ab52635/ck53.jpg)
A431 cells stained with ab52635 at 1/100 - 1/250
2
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"
Call 01223 696 000 or contact us
